通过对肠道微生物群和代谢物进行表征,分析肺功能受损患者的肺癌风险

Jiahui Luan1,2, Fuxin Zhang1,2, Lijun Suo3,2

  • 1Department of Clinical Microbiology, Zibo City Key Laboratory of Respiratory Infection and Clinical Microbiology, Zibo City Engineering Technology Research Center of Etiology Molecular Diagnosis, Zibo Municipal Hospital, Zibo, 255400, China.

BMC pulmonary medicine
|January 3, 2024
PubMed
概括

肠道微生物组和代谢物分析可以预测肺癌 (LC) 患者的肺功能受损. 特定的肠道细菌和代谢物可以作为肺功能障碍LC的诊断生物标志物.